1181 related articles for article (PubMed ID: 25759096)
1. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
Kennedy EM; Cullen BR
Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
Gasiunas G; Siksnys V
Trends Microbiol; 2013 Nov; 21(11):562-7. PubMed ID: 24095303
[TBL] [Abstract][Full Text] [Related]
4. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
Steinert J; Schiml S; Fauser F; Puchta H
Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
[TBL] [Abstract][Full Text] [Related]
5. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Chylinski K; Le Rhun A; Charpentier E
RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
[TBL] [Abstract][Full Text] [Related]
6. Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing.
Kaulich M; Dowdy SF
Nucleic Acid Ther; 2015 Dec; 25(6):287-96. PubMed ID: 26540648
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
8. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
9. Programmable DNA cleavage in vitro by Cas9.
Karvelis T; Gasiunas G; Siksnys V
Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
[TBL] [Abstract][Full Text] [Related]
10. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
Karvelis T; Gasiunas G; Miksys A; Barrangou R; Horvath P; Siksnys V
RNA Biol; 2013 May; 10(5):841-51. PubMed ID: 23535272
[TBL] [Abstract][Full Text] [Related]
11. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
Altenbuchner J
Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
[TBL] [Abstract][Full Text] [Related]
12. The Anti-CRISPR Story: A Battle for Survival.
Maxwell KL
Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
[TBL] [Abstract][Full Text] [Related]
13. DNase H Activity of Neisseria meningitidis Cas9.
Zhang Y; Rajan R; Seifert HS; Mondragón A; Sontheimer EJ
Mol Cell; 2015 Oct; 60(2):242-55. PubMed ID: 26474066
[TBL] [Abstract][Full Text] [Related]
14. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
[TBL] [Abstract][Full Text] [Related]
15. Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response.
Heler R; Wright AV; Vucelja M; Bikard D; Doudna JA; Marraffini LA
Mol Cell; 2017 Jan; 65(1):168-175. PubMed ID: 28017588
[TBL] [Abstract][Full Text] [Related]
16. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
Yin LJ; Hu SQ; Guo F
Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
[TBL] [Abstract][Full Text] [Related]
17. The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells.
Lee CM; Cradick TJ; Bao G
Mol Ther; 2016 Mar; 24(3):645-54. PubMed ID: 26782639
[TBL] [Abstract][Full Text] [Related]
18. A newly discovered Bordetella species carries a transcriptionally active CRISPR-Cas with a small Cas9 endonuclease.
Ivanov YV; Shariat N; Register KB; Linz B; Rivera I; Hu K; Dudley EG; Harvill ET
BMC Genomics; 2015 Oct; 16():863. PubMed ID: 26502932
[TBL] [Abstract][Full Text] [Related]
19. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
[TBL] [Abstract][Full Text] [Related]
20. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
